• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home 2021 October 27

Post Archive by Day

View Post

Cost-Sharing Waivers Did Not Cover All COVID-19 Hospital Care in 2020

In COVID-19, Latest News
by Healthday
October 27, 2021

Mean out-of-pocket spending was $3,840 for privately insured patients with COVID-19 hospitalizations

View Post

For Dialysis Recipients, Antibody Response Lowest With Ad26.COV2.S

In COVID-19, Latest News
by Healthday
October 27, 2021

Patients receiving attenuated adenovirus vaccine more likely to have no seroconversion, no detectable or diminished IgG response

View Post

Merck Allows Poor Nations to Make COVID-19 Pill

In COVID-19, Latest News
by Healthday
October 27, 2021

Royalty-free license means companies in 105 countries can sublicense the formulation for antiviral pill molnupiravir and start making it

View Post

Immunocompromised May Need Fourth COVID-19 Shot: CDC

In COVID-19, Latest News
by Healthday
October 27, 2021

Small studies have shown that fully vaccinated immunocompromised people account for ~44 percent of breakthrough cases leading to hospitalization

View Post

American Academy of Pediatrics, Oct. 8 to 11

In COVID-19, Latest News
by Healthday
October 27, 2021

The American Academy of Pediatrics National Conference & Exhibition

TRENDING

  • Dupilumab Studied in Patients Hospitalized for COVID-19
  • Neurologic Complications Common in Children Hospitalized With COVID-19
  • COVID-19 Risk for Dialysis Patients Tied to Antibody Response to Vaccine
  • First Lady Jill Biden Has COVID-19
  • Multidose BCG Protects Against COVID-19 in At-Risk Individuals

By Publish Date

October 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Sep   Nov »

LATEST ARTICLES

  • Dupilumab Studied in Patients Hospitalized for COVID-19 August 16, 2022
  • Neurologic Complications Common in Children Hospitalized With COVID-19 August 16, 2022
  • COVID-19 Risk for Dialysis Patients Tied to Antibody Response to Vaccine August 16, 2022

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines